Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Japan Regulatory News (SJG)

Share Price Information for Schroder Japan (SJG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 261.00
Bid: 261.00
Ask: 262.00
Change: 9.00 (3.57%)
Spread: 1.00 (0.383%)
Open: 260.00
High: 263.00
Low: 260.00
Prev. Close: 252.00
SJG Live PriceLast checked at -
Schroder Japan Growth is an Investment Trust

To achieve capital growth from an actively managed portfolio principally comprising securities listed on the Japanese stock markets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Enhanced Dividend and Discount Management Policy

24 Jun 2024 07:00

RNS Number : 4624T
Schroder Japan Trust PLC
24 June 2024
 

Schroder Japan Trust plc

 

Enhanced Dividend and Discount Management Policy

 

Monday, 24 June 2024

 

The Board of Schroder Japan Trust plc (the "Company") announces a package of dividend and discount management measures following an internal review and after discussion with the Company's largest shareholders.

 

Enhanced Dividend Policy

 

The Board believes that when investing in Japan, dividends will continue to play an increasingly important part of shareholder return. Several years ago, the Board highlighted the growing contribution from the dividends paid, given the focus of Japanese corporates on improving shareholder value and good corporate governance practice.

 

Whilst the Company has been able to grow dividends by 12.7% on an average yearly basis over the past 10 years, the Board would now like to adopt an enhanced dividend policy to pay out 4% of average net asset value in each financial year. Further details will be provided in the Annual Report.

 

It is important to note that the enhanced dividend policy will not result in a change to the Company's investment approach and strategy. The Company's focus will continue to be on well -managed, high-quality companies where the current share price does not yet fully reflect their potential, across the complete spectrum of Japanese companies.

 

 

Discount Management Policy

 

In August 2020, the Company put in place a Conditional Tender Offer mechanism, since that time the Portfolio Manager has meet the requirements and has delivered sustained outperformance relative to the Benchmark, such outperformance compounding at 4.67% per annum to 31st May 2024. Accordingly, it is expected that the Company will meet the outperformance target, with the result that no tender offer will be triggered on 31 July 2024.

 

The Board now proposes a new Conditional Tender Offer mechanism. In the event that the manager does not deliver performance at least in line with the Tokyo Stock Price Index Total Return in sterling terms (the "Benchmark") over a five-year period starting from 31st July 2024, then the Board will put to shareholders a proposal for a tender offer of 25% of the issued share capital at a price equal to the prevailing net asset value less costs. 

 

In addition to the above proposal, the Company will continue to maintain its share buyback policy where appropriate.

 

The Board believes that the measures outlined above will improve the attractiveness of an investment in the Company.

 

The Chairman Dr Philip Kay said: "The Company has achieved sustained outperformance over the last four years and my fellow directors and I believe that an annual 4% of NAV dividend and the new five-year Conditional Tender Offer is a great package for all our investors".

 

 

Enquiries

 

Company Secretary

 

Katherine Fyfe +44 20 7658 3136

 

 

Public Relations

 

Kirsty Preston +44 20 7658 1961

 

 

Corporate Broker

 

J.P. Morgan Cazenove +44 20 3493 8000

 

William Simmonds

Jérémie Birnbaum

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRPPUUCQUPCGAG
Date   Source Headline
30th Jan 202410:30 amRNSNet Asset Value(s)
29th Jan 202411:15 amRNSNet Asset Value(s)
26th Jan 20245:48 pmRNSTransaction in Own Shares
26th Jan 202410:30 amRNSNet Asset Value(s)
25th Jan 202410:59 amRNSNet Asset Value(s)
24th Jan 202410:29 amRNSNet Asset Value(s)
23rd Jan 202411:10 amRNSNet Asset Value(s)
22nd Jan 202410:39 amRNSNet Asset Value(s)
19th Jan 20244:55 pmRNSTransaction in Own Shares
19th Jan 202410:15 amRNSNet Asset Value(s)
18th Jan 20244:24 pmRNSHolding(s) in Company
18th Jan 20243:40 pmRNSHolding(s) in Company
18th Jan 202410:15 amRNSNet Asset Value(s)
17th Jan 202410:44 amRNSNet Asset Value(s)
16th Jan 20244:39 pmRNSHolding(s) in Company
16th Jan 202410:39 amRNSNet Asset Value(s)
15th Jan 20244:16 pmRNSHolding(s) in Company
15th Jan 202410:25 amRNSNet Asset Value(s)
12th Jan 202410:20 amRNSNet Asset Value(s)
11th Jan 20245:13 pmRNSHolding(s) in Company
11th Jan 20245:11 pmRNSHolding(s) in Company
11th Jan 202412:00 pmRNSNet Asset Value(s)
10th Jan 202411:28 amRNSNet Asset Value(s)
9th Jan 202411:03 amRNSNet Asset Value(s)
8th Jan 202410:28 amRNSNet Asset Value(s)
5th Jan 20245:05 pmRNSTransaction in Own Shares
5th Jan 20244:58 pmRNSPortfolio Update
5th Jan 202410:25 amRNSNet Asset Value(s)
4th Jan 202411:33 amRNSNet Asset Value(s)
3rd Jan 202412:39 pmRNSNet Asset Value(s)
2nd Jan 202410:45 amRNSNet Asset Value(s)
29th Dec 202312:48 pmRNSTotal Voting Rights
29th Dec 202312:21 pmRNSTransaction in Own Shares
29th Dec 202310:17 amRNSNet Asset Value(s)
28th Dec 20234:46 pmRNSHolding(s) in Company
28th Dec 202310:38 amRNSNet Asset Value(s)
27th Dec 202311:49 amRNSNet Asset Value(s)
22nd Dec 20231:07 pmRNSHolding(s) in Company
22nd Dec 20231:06 pmRNSTransaction in Own Shares
22nd Dec 202310:56 amRNSNet Asset Value(s)
21st Dec 202311:23 amRNSNet Asset Value(s)
20th Dec 202311:53 amRNSNet Asset Value(s)
19th Dec 202310:30 amRNSNet Asset Value(s)
18th Dec 202310:46 amRNSNet Asset Value(s)
18th Dec 20237:00 amRNSKepler Trust Intelligence: New Research
15th Dec 202310:50 amRNSNet Asset Value(s)
14th Dec 202310:53 amRNSNet Asset Value(s)
13th Dec 202310:44 amRNSNet Asset Value(s)
12th Dec 202310:43 amRNSNet Asset Value(s)
11th Dec 202311:13 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.